On December 10, 2024, we had a look at the weekly chart of BA Boeing and it was a very good opportunity to get into this stock. Since then, we made over 20% in under one month.
After consolidating for nearly three weeks, we may have another chance to get in for the next leg up to $200. The only thing to worry about are the earnings on January 28. Those could have a huge impact on the stock price, but chances are the impact will be positive. Since 2024 was a very challenging year for Boeing with lower net orders booked compared to Airbus the comparisons are much easier to beat than it is for Airbus.
Boeing experienced a decline in various metrics last year. The company recorded 569 gross orders, representing a 61% decrease compared to the previous year. Cancellations increased by 50 units, mainly due to the anticipated cancellation of 135 jets ordered by Jet Airways. Net orders fell by 71% to 377 orders, and the net order value also decreased by 71% to $33 billion. This reduction in orders is attributed to the uncertainty surrounding Boeing's production schedule, which makes it less attractive for airplane orders. Deliveries fell by 34% to 348, and the delivery value decreased by 35% to $26.1 billion due to the grounding of the Boeing 737 MAX 9 and a subsequent strike.
If we assume no further crashes or problems with Boeing aircrafts the numbers are easier to beat, and we come from a very low base. In addition, most analysts are quite conservative right now.
Looking at the technical setup we just bounced from the 0.382 fib from the current upward movement. Below the fib we have another support at around $160 as well as a resistance at $200 with an open gap. Assuming no surprises during the earnings we’re up for another leg up to $200 (15% ROI).
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.